# A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers

> **NCT02005211** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 114 (actual)

## Conditions studied

- Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers

## Interventions

- **DRUG:** AZD3293
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02005211
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2016-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005211, "A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02005211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*